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CASE PRESENTATION
A 51-year-old woman with a history of an olfactory
neuroblastoma treated with radiation, chemotherapy, and
surgical resection 13 years ago was admitted for evaluation
and treatment of persistent nausea, vomiting, fatigue, and
dehydration. The patient suffered from significant cosmetic
defects since resection of the neuroblastoma, and had
undergone a left eyebrow lift 1 year before presentation for
chronic left facial droop. The surgery was complicated by
recurrent left scalp wound infections requiring long
antibiotic courses. Owing to the persistence of infection
despite appropriate antibiotic therapy, she underwent
partial resection of a mesh in the wound 3 weeks before
presentation. She was doing well after this procedure until
2 days before admission, when she developed persistent
nausea, vomiting, and diarrhea. She was subsequently
admitted for further evaluation and treatment.
Other than the neuroblastoma, her past medical history
was remarkable only for depression. Her outpatient
medications at the time of admission included intravenous
vancomycin and piperacillin/tazobactam, rifampin,
amitriptyline at a stable dose for the past 6 months,
and vitamin B6 supplements. She was unemployed, did
not use tobacco or alcohol, and lived with her husband.
She had one child, a daughter, who is a registered nurse.
Her vital signs on admission were notable for a
temperature of 981F, pulse of 75/min, and blood pressure
of 84/50 mm Hg. Her blood pressure before surgery
averaged around 105/70 mmHg. Orthostatic vital signs
were not able to be obtained owing to extreme dizziness
when she attempted to stand or sit up. Her physical exam
was notable for dry mucous membranes, flat neck veins,
clear lungs, benign abdominal examination, no lower
extremity edema, and markedly decreased skin turgor.
Initial laboratory results included were Na 120 mmol/l (her
most recent serum Na 4 weeks ago was 140 mmol/l),
K 3.0 mmol/l, Cl 87 mmol/l, HCO3 22.0 mmol/l, blood urea
nitrogen 5 mg/dl, Cr 0.6 mg/dl, and serum osmolality
242 mosm/kg (Table 1). Urine electrolytes obtained on the
same afternoon of admission were notable for Na
110 mmol/l and osmolality 351 mosm/kg (Table 2). Her
white blood cell count was 4100/ml, hemoglobin 10.6 g/dl,
hematocrit 28.1%, and platelets 251 000/ml. Her serum
glutamic pyruvic transaminase (SGPT) was 66 U/l, serum
glutamic oxaloacetic transaminase (SGOT) 50 U/l, and
albumin was 3.2 g/dl. Her uric acid level was 2.2 mg/dl. Her
urinalysis had an specific gravity (SPGR) of 1.019, pH of
6.5, and was negative for leukocytes, heme, and glucose.
A chest radiograph was unremarkable.
She was initially treated with intravenous normal saline
with 5% dextrose for a total of 2.4 l and anti-emetics
through the first 2 days of admission. With this regimen
her serum sodium increased from 120 to 123 mmol/l
(Table 1 and Figure 1), although she remained hypo-
tensive and orthostatic. Repeat urine electrolytes were
notable for Na 222 mmol/l, K 36.8 mmol/l, and osmolality
550 mosm/kg (Table 2). Owing to the increase in urine
osmolality, she was placed on a 1 l daily fluid restriction to
treat presumed syndrome of inappropriate antidiuretic
hormone (SIADH). After 2 days of fluid restriction, she
remained hypotensive and her serum sodium decreased
to 118 mmol/l. A renal consult was then obtained on the
fourth hospital day for ‘refractory SIADH.’
Her vital signs at the time of renal consultation
included a blood pressure of 80/61 mmHg, a heart rate
of 66/min, and a temperature of 98.81F. Her physical
examination was again notable for dry mucous mem-
branes, marked skin tenting, and inability to obtain
orthostatic vital signs owing to dizziness with sitting or
standing. Her thyroid and adrenal function were tested
and were found to be normal. Owing to prominent signs
of extracellular fluid (ECF) contraction, her fluid restriction
was discontinued, and she was started on a normal saline
infusion at 100 ml/h (hospital day 4). Within the first 24 h
of normal saline infusion, her serum sodium increased
from 118 to 132 mmol/l (Table 1 and Figure 1), and her
urine output was noted to increase from an average of
600 ml/day in the preceding 2 days to 3.6 l over the course
of the next day. Her urine electrolytes, however, continued
to demonstrate inappropriate natriuresis in the face of
persistent hyponatremia and signs and symptoms of ECF
contraction, and her serum sodium again fell after hospital
day 5 when continuous IV saline infusions were stopped
and sporadic IV saline boluses were administered instead
(Table 1 and Figure 1). An magnetic resonance imaging of
http://www.kidney-international.org t h e r e n a l c o n s u l t
& 2007 International Society of Nephrology
Received 5 April 2006; revised 23 July 2006; accepted 1 August 2006;
published online 20 September 2006
Correspondence: OM Gutierrez, Nephrology Division, Massachusetts
General Hospital and Harvard Medical School, 55 Fruit Street, GRB 1003,
Boston, Massachusetts 02114, USA. E-mail: ogutierrez@partners.org
Kidney International (2007) 71, 79–82. doi:10.1038/sj.ki.5001845;
published online 20 September 2006
Kidney International (2007) 71, 79–82 79
the brain obtained 2 days later revealed two basal frontal
lobe lesions demonstrating relatively thin peripheral
enhancement, most compatible with abscesses or
residual/recurrent tumor (Figure 2). On hospital
day 10, her sodium balance was estimated to be
negative by 406 mEq with a urine output of 5.8 l the
preceding 24 h despite remaining hypotensive and
orthostatic.
CLINICAL DIAGNOSIS
Hyponatremia secondary to cerebral salt wasting (CSW).
CLINICAL FOLLOW-UP
Her serum sodium remained exquisitely sensitive to sodium
intake, predictably rising with resumption of continuous IV
normal saline infusions after the diagnosis of CSW was made
on hospital day 10 (Figure 1). In order to increase and
maintain her serum sodium between 135 and 140 mmol/l,
she required on average 3–3.5 l of IV normal saline and salt
tablets on a daily basis to keep her total body sodium balance
positive on average 275 mEq a day. A biopsy of the lesions
discovered by magnetic resonance imaging revealed only
necrotic tissue without any evidence of malignancy, thought
possibly to be owing to infection or post-radiation changes.
The scalp mesh was removed in a subsequent surgery, and she
was eventually discharged 3 weeks after admission to a skilled
nursing facility. Her sodium on discharge was 136, and she
was discharged only on salt tablets (2 g by mouth four times
a day).
DISCUSSION
CSW remains one of the most difficult causes of hypo-
natremia to diagnose in hospitalized patients owing to its
frequent confusion with syndrome of inappropriate anti-
diuretic hormone (SIADH). This is because both syndromes
share certain key features: low serum sodium, low serum
osmolality, a higher urine osmolality than serum osmolality,
Table 1 | Serum electrolytes, BUN, and creatinine
by hospital day
Day 1 Day 2 Day 4 Day 5 Day 8 Day 10 Day 12
Na (mmol/l) 120 123 118 132 128 125 133
K (mmol/l) 3.0 4.1 3.7 3.5 4.1 3.7 4.0
Cl (mmol/l) 87 101 83 102 96 95 101
HCO3 (mmol/l) 22 22.6 22 22 24.2 22.1 23.1
BUN (mg/dl) 5 4 7 6 4 3 2
Creatinine (mg/dl) 0.6 0.6 0.7 0.7 0.7 0.6 0.7
BUN, blood urea nitrogen.
Table 2 | Urine electrolytes, creatinine, osmolality, and FeNa
by hospital day
Day 1 Day 2 Day 4 Day 8 Day 10 Day 12
Na (mmol/l) 148 222 191 87 163 182
K (mmol/l) 36.8 27.7 41.1 21.5
Cl (mmol/l) 201 180 185
Creatinine (mg/ml) 0.25 0.49 0.76 0.33 0.29 0.22
Osm (mosm/kg) 351 550 610 328 385 389
FeNa (%) 2.96 2.21 1.5 1.5 2.7 4.3
FeNa, fractional excretion of sodium.
600
550
500
400
350
300
250
200
450
O
sm
ol
al
ity
 (m
Os
m/
kg
)
140
135
130
125
120
115
110
105
100
Se
ru
m
 s
od
iu
m
 (m
mo
l/l)
Serum osm
Serum Na
Urine osmolality
I.V.saline
I.V.saline
saline boluses
Fluid restriction
Continuous
Intermittent I.V.
Continuous I.V. saline resumed
Day 1 Day 2 Day 4 Day 5 Day 8 Day 10 Day 12
Hospital day
Figure 1 | Serum osmolality, urine osmolality, and serum sodium
per hospital day and intervention.
Figure 2 | Brain magnetic resonance imaging showing two
ring enhancing lesions in the basal frontal lobes bilaterally
(right lesion 1.8 by 2.0 cm in dimension, left 1.4 by 1.1 cm),
demonstrating relatively thin peripheral enhancement on
T2 weighted images consistent with either abscesses, residual
tumor, or post-radiation necrosis.
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and an elevated urinary sodium concentration.1 Further-
more, the features of CSW which distinguish it from SIADH
– namely extracellular fluid (ECF) contraction and inappro-
priately negative sodium balance – are often difficult to
establish beyond a reasonable doubt, even with invasive
testing or a myriad of serologic markers, further contributing
to the difficulty of making this diagnosis.2 Nevertheless, this
is hardly a trivial distinction to be made, as the management
of the two conditions differs markedly, and if the wrong
treatment algorithm is chosen, there can be serious
consequences including worsening of hyponatremia and,
more rarely, cerebral ischemia.3
The principal features of CSW generally include hypo-
natremia and ECF contraction owing to renal sodium
wasting in the setting of intracranial disease.4 A variety of
processes have been linked with CSW, including subarach-
noid hemorrhage, encephalitis, poliomyelitis, tuberculous
meningitis, craniotomy, and tumors, among others.4 In
addition, a number of human and animal models of disease
have consistently supported a distinct association between
intracranial injury and disordered renal sodium regulation
leading to volume depletion and hyponatremia.5,6 The
mechanisms behind these associations, however, are less
clear, although a number of theories have been proposed.
One of the first was that CSW is a misnomer for SIADH after
the first description of SIADH was published in 1957.7
However, in several models of severe brain injury associated
with the development of hyponatremia, antidiuretic hor-
mone was found to be elevated only in the first few days after
the injury was sustained, subsequently declining to normal
levels in the face of prolonged and inappropriate natriuresis,
suggesting that hyponatremia after the first few days of brain
injury in these cases was caused by some mechanism other
than abnormally elevated ADH levels.5,6 The observation that
hyponatremia in other similar cases was successfully treated
with volume resuscitation instead of fluid restriction,8 as
would be the recommended therapy in SIADH, further
bolstered the case for CSW as a disorder which is distinct
from SIADH. Disruptions of neuronal control of renal
sodium handling have been frequently postulated to be the
cause of CSW, either through the interruption of sympathetic
regulation of sodium absorption,9 or the elaboration of
circulating natriuretic factors from neuronal cells.4 Potential
candidates for such factors include ouabain-like com-
pounds;10 atrial natriuretic peptide, which has been isolated
in neurons of rats;11,12 and brain natriuretic peptide.13–15
Despite a few promising studies linking some of these factors
to CSW, none of them have been consistently shown to be the
primary cause of renal sodium wasting and volume depletion
in human or animal models of intracranial disease, making it
difficult to rely on them as definitive markers of disease.
As mentioned, the difficulty in conclusively diagnosing
CSW rests in attempting to distinguish it from other more
common causes of hyponatremia, such as SIADH or sodium
depletion from non-renal causes. Much of the problem
tends to arise from trying to establish that a patient is
hyponatremic owing to inappropriate natriuresis (to distin-
guish it from non-renal sodium depletion) and that the
patient is truly volume contracted (to distinguish it from
SIADH). In the case presented, it was initially assumed that
the patient was hyponatremic owing to non-renal sodium
losses as a consequence of repeated emesis and poor oral
intake in the days before admission. However, closer scrutiny
of her urine electrolytes did not corroborate this initial
assumption as her urine sodium was inappropriately elevated
(110 mmol/l) in this setting. Normally, in the absence of
sodium wasting nephropathies, severe renal impairment,
defects in the renin–aldosterone axis, or diuretic treatment,
her urine sodium concentration should have been much
lower owing to avid compensatory sodium reabsorption in
the case of extra-renal sodium depletion.16 Furthermore,
after an initial trial of volume resuscitation with normal
saline, her urine sodium concentration markedly increased
(Table 1), perpetuating an inappropriate natriuresis. Im-
portantly, the calculation of a negative sodium balance on
hospital day 10 was an important clue that the natriuresis was
due to abnormal renal sodium losses and was not an
appropriate physiological response to intravenous volume
loading.17
Establishing that the patient is truly volume contracted is
a more difficult and controversial task. The imprecision
of judging ECF status by physical signs and symptoms alone
is well documented.2 Nevertheless, more invasive measures
of volume, such as measuring the central venous pressure
or pulmonary artery occlusion pressure, are often impractical
and unwarranted, particularly in standard clinical practice,
leaving physical examination findings as the most practical
measures of generalized volume status available to the
clinician. The patient in this case report had a variety of
signs and symptoms suggesting volume contraction, which
were observed by numerous examiners. Serologic markers of
volume depletion, such as an increased red blood cell and
plasma volume; elevated blood urea nitrogen:creatinine
ratios; depressed serum urate and elevated fractional
excretion of urate (X10%) after correction of the serum
sodium (which some have advocated as a method to
distinguish CSW from SIADH1); and elevated plasma renin
activity and aldosterone, have proven to be equally
disappointing in serving as sensitive or specific indicators
of CSW.1 In light of this fact, we did not place a great deal of
emphasis on measuring many of these factors outside of
those values available through routine lab draws. Instead, the
combination of physical examination signs and symptoms
suggesting volume depletion, urinary sodium losses that were
inappropriately elevated, hyponatremia, and radiologic
imaging demonstrating cerebral lesions suggested CSW as
the most likely root cause of her hyponatremia. We
acknowledge that there was a discrepancy between her pulse
rate and hypotension in that she never demonstrated
tachycardia despite other evidence of volume contraction.
This might suggest autonomic failure as one potential cause
of her persistent hypotension. However, given the fact that
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she did not have a history of orthostatic hypotension,
syncope, or pre-syncope, we felt that this was unlikely in her
case. Furthermore, as hypotension owing to automonic
failure is caused by decreased sympathetic nervous system
activation, which itself is one potential mechanism of CSW as
mentioned above, even if this were the root cause of her
hypotension, her hyponatremia could still be due to CSW as
decreased symphathetic input would have contributed to the
urinary sodium wasting which she demonstrated. Finally, the
fact that her hyponatremia worsened with fluid restriction
but responded to saline volume resuscitation and oral
sodium loading provided further evidence that she had this
rare cause of sodium wasting.
Management of CSW includes treatment of the underlying
cerebral disorder, volume resuscitation, and sodium replace-
ment.4 Generally, the latter two can be accomplished with
intravenous isotonic saline solutions and oral salt tablets,
with hypertonic saline reserved for particularly severe or
refractory cases. Gradual correction of the serum sodium
over several days is most safe and appropriate, especially in
cases where hyponatremia has been present for an extended
period of time. Enhancing renal tubular sodium absorption
with mineralocorticoids such as fludrocortisone acetate
can also help mitigate excessive urinary sodium losses.
Fludrocortisone has been shown to be a useful adjunct in
reducing water and sodium excretion, and improving
hyponatremia with less ongoing volume losses in cases of
CSW.18,19
CSW remains a difficult diagnosis to make in hospitalized
patients with hyponatremia, especially in terms of distin-
guishing it from other more common causes such as extra-
renal sodium losses and SIADH. The key to diagnosis rests in
demonstrating that hyponatremia is secondary to inappro-
priately high urinary sodium excretion in a patient who is
volume contracted. Once the diagnosis is established,
treatment includes addressing the underlying cerebral
disorder, sodium loading through intravenous and oral
routes, hydration, and, in some cases, administration of
mineralocorticoids such as fludrocortisone acetate (Table 3).
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Table 3 | Differences in clinical features and treatment
between SIADH and CSW
SIADH CSW
Clinical features
Volume status
CVP/PAOP Normal to high Low
Postural
hypotension
Absent Present
Red cell volume Normal to high Low
Plasma volume Normal to high Low
Plasma rennin Normal Normal to high
Plasma
aldosterone
Normal Normal to high
Serum urate Low Low
Fractional
excretion of urate
Normal after
correction of Serum
sodiuma
Elevated after
correction of serum
sodiuma
ADH Elevated Normal to high
BNP Normal Normal to high
ANP Normal Normal to high
Treatment
Free water restriction
hypertonic saline
infusion loop
diuretics high solute
intake
demeclocycline
Salt loading volume
replacement
fludrocortisone
acetate
ADH, antidiuretic hormone; ANP, atrial natriuretic peptide; BNP, brain natriuretic
peptide; CSW, cerebral salt wasting; CVP, central venous pressure; PAOP, pulmonary
artery occlusion pressure; SIADH, syndrome of inappropriate antidiuretic hormone.
aSome have advocated that an FEurate X10% after correction of serum sodium is
elevated and consistent with CSW, whereas a level o10% is consistent with SIADH.
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